Physician

Caleb J Scheckel, D.O.

According to 2025 Medicare claims, Caleb Scheckel, D.O. (NPI: 1447606348) practices hematology/oncology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (NPI: 1962876045; TIN: 383983999) and primary practice location at 74146-6236.

Scheckel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 821 traditional Medicare patients, billed 171,529 HCPCS/CPT codes, and received $3,324,975 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 2,026 prescription claims across 198 beneficiaries totaling $7,706,376 in drug costs, led by Revlimid (Lenalidomide). Open Payments data shows 58 records totaling $110,640. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,278 to $3,324,975. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,174 to $7,706,376. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	34	49	$4,278
2020	73	132	$11,066
2021	113	218	$24,750
2022	91	669	$24,943
2023	705	153,106	$2,628,376
2024	821	171,529	$3,324,975

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	19	44	$4,174
2017	61	194	$9,544
2018	61	193	$10,306
2019	31	150	$9,178
2020	44	179	$37,607
2021	47	222	$303,601
2022	54	237	$196,929
2023	185	1,479	$4,551,715
2024	198	2,026	$7,706,376

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	249	1,897	$10
36415	Insertion of needle into vein for collection of blood sample	251	1,541	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	265	2,111	$8
83735	Magnesium level	248	1,903	$7
83615	Lactate dehydrogenase (enzyme) level	248	1,904	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	120	3,360	$2,275,429
Brukinsa	Zanubrutinib	59	1,770	$716,860
Pomalyst	Pomalidomide	28	784	$616,690
Imbruvica	Ibrutinib	32	896	$597,675
Calquence	Acalabrutinib Maleate	31	930	$498,750

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$45,787	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$64,853	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Caleb J. Scheckel, D.O.?

Tedicare shows public-source Medicare data for Caleb J. Scheckel, D.O. (NPI 1447606348), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Caleb J. Scheckel, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Caleb J. Scheckel, D.O.?

Caleb J. Scheckel, D.O. is linked to OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (billing NPI 1962876045) in the available physician profile data.

Does Caleb J. Scheckel, D.O. have Open Payments data?

Caleb J. Scheckel, D.O. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.